Indicators
Indicators
Value
Direction
MACD(12,26,9)
-0.277
Sell
RSI(14)
40.103
Neutral
STOCH(KDJ)(9,3,3)
13.030
Oversold
ATR(14)
0.354
High Vlolatility
CCI(14)
-113.744
Sell
Williams %R
93.333
Oversold
TRIX(12,20)
-0.231
Sell
StochRSI(14)
0.000
Sell
Search
Telix Pharmaceuticals Ltd
TLXAdd to Watchlist
9.910USD
-0.150-1.49%
Close 07-31 16:00（ET）Quotes delayed by 15 min
0.00Market Cap
--P/E TTM
View Detailed Chart
TradingKey ChartIntraday
1m
30m
1h
D
W
M
D
Today
-1.49%
5 Days
-3.03%
1 Month
-16.30%
6 Months
+36.13%
Year to Date
+32.31%
1 Year
-27.08%
Key Figures
10.000Open
10.012High
80.93KVolume
--P/E TTM
0.00P/E Dynamic
--Dividend TTM
--Turnover Ratio
10.060Prev. Close
9.790Low
612.50KTurnover
--P/E Static
--P/B
0.00%Div Yield TTM
--ROA
18.49052wk High
1.02Volume Ratio
--Net Profit
--Shares
--EPS TTM
--Beta
--ROE
6.28052wk Low
2.21%Amplitude
--Gross Margin
0.00Market Cap
-8.69Reward/Risk
1.75%Risk Rate
Telix Pharmaceuticals Ltd News
More news coming soon, stay tuned...
Earnings Forecast
Analyst Rating
Based on
5
analysts
Strong Buy
Current Rating
19.291
Target Price
+91.00%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
496
Total
6
Median
7
Average
Company name
Ratings
Analysts
Telix Pharmaceuticals Ltd
TLX
5
Beigene Ltd
ONC
27
argenx SE
ARGX
26
IQVIA Holdings Inc
IQV
26
Ionis Pharmaceuticals Inc
IONS
25
Insmed Inc
INSM
23
1
2
3
...
99
Indicators
Moving Average
Indicators
Value
Direction
MA5
10.044
Sell
MA10
10.270
Sell
MA20
10.781
Sell
MA50
10.310
Sell
MA100
10.074
Sell
MA200
9.305
Buy
Telix Pharmaceuticals Ltd Info
Telix Pharmaceuticals Limited is an Australia-based biopharmaceutical company focused on the development and commercialization of therapeutic and diagnostic radiopharmaceuticals and associated medical technologies. It is developing a portfolio of clinical and commercial stage products that aims to address significant unmet medical needs in oncology and rare diseases. Its segments include Therapeutics, Precision Medicine and Telix Manufacturing Solutions. Therapeutics segment develops targeted radionuclide therapies for urologic, neurologic, musculoskeletal and hematological cancers. Precision Medicine segment focuses on bringing diagnostic imaging solutions to market. Precision Medicine segment also includes MedTech and International businesses. Telix Manufacturing Solutions segment is its global network of facilities designed to deliver patient doses worldwide. Its pipeline products include TLX591, TLX250, TLX101, TLX66, TLX592, TLX252, TLX400, Illuccix (68Ga-PSMA-11) and TLX007-CDx.
Ticker SymbolTLX
CompanyTelix Pharmaceuticals Ltd
CEOOrtiz (Raphaeel)
Websitehttps://telixpharma.com/
Shareholders
Popular Instruments
52378.000
+109.000 (+0.21%)
28160.900
-37.600 (-0.13%)
7475.100
+30.800 (+0.41%)
14749.000
-90.000 (-0.61%)
62852.000
-742.000 (-1.17%)
6365.400
-1.000 (-0.02%)
85.934
+2.764 (+3.32%)
308.640
-24.790 (-7.43%)
200.760
+5.720 (+2.93%)
4041.430
-61.400 (-1.50%)
FAQs
What is the current price of Telix Pharmaceuticals Ltd (TLX)?
The current price of Telix Pharmaceuticals Ltd (TLX) is 9.91.
What is the symbol of Telix Pharmaceuticals Ltd?
The ticker symbol of Telix Pharmaceuticals Ltd is TLX.
What is the 52-week high of Telix Pharmaceuticals Ltd?
The 52-week high of Telix Pharmaceuticals Ltd is 18.49.
What is the 52-week low of Telix Pharmaceuticals Ltd?
The 52-week low of Telix Pharmaceuticals Ltd is 6.28.
Is Telix Pharmaceuticals Ltd (TLX) currently rated as Buy, Hold, or Sell?
According to analysts, Telix Pharmaceuticals Ltd (TLX) has an overall rating of STRONG BUY, with a price target of 19.29.